Description
CD ComputaBio’s core Drug Design Services deliver an end-to-end computational pipeline to transform biological insights into viable drug candidates. This service covers the full spectrum of Computer-Aided Drug Design (CADD), including high-throughput virtual screening, structure-based and ligand-based drug design, pharmacophore modeling, and lead optimization. By evaluating toxicity, developability, and target selectivity in silico, we empower biopharmaceutical clients to accelerate discovery timelines and minimize experimental attrition rates.